Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kalaris Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kalaris Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Vandekop Amy O'Leary | VP, Corporate Controller | – | Aug 28, 2026 | 1 |
| Keating Laurie | Director | – | Aug 3, 2026 | 1 |
| Bayko Liisa Ann | Chief Financial Officer | – | Jul 20, 2026 | 1 |
| Patterson Leone D | Director | – | Jun 4, 2026 | 1 |
| Akkaraju Srinivas | Director | 19,408Indirect | Jun 4, 2026 | 4 |
| Adamis Anthony P | Director | – | Jun 4, 2026 | 1 |
| Hallal David | Director | 2,143,662 | Jun 4, 2026 | 1 |
| Jovan-Embiricos Morana | Director | 100,197 | Jun 4, 2026 | 1 |
| Dybbs Michael | Director | – | Jun 4, 2026 | 1 |
| Ferrara Napoleone | Director | 504,000 | Jun 4, 2026 | 1 |
| Samsara BioCapital, L.P. | 10% Owner | 19,408Indirect | May 22, 2026 | 2 |
| Samsara BioCapital GP, LLC | 10% Owner | 19,408Indirect | May 22, 2026 | 2 |
| Samsara Opportunity Fund, L.P. | 10% Owner | 19,408Indirect | May 22, 2026 | 3 |
| Samsara Opportunity Fund GP, LLC | 10% Owner | 19,408Indirect | May 22, 2026 | 3 |
| Hagen Brett R | Chief Accounting Officer | 0 | Mar 23, 2026 | 1 |
| Feinsod Matthew | Chief Medical Officer | 4,030 | Mar 20, 2026 | 1 |
| Oxtoby Andrew | See Remarks | – | Mar 20, 2026 | 1 |
| Gall Matthew | Chief Financial Officer | – | Mar 20, 2026 | 2 |
| Patel Samir Chandrakant | Director | 100,800Indirect | Apr 11, 2025 | 0 |
| Sinha Vikas | See Remarks | 49,129 | Feb 24, 2025 | 0 |
| Miller Edward | General Counsel | 6,517 | Feb 24, 2025 | 0 |
| Brainard Diana | Chief Executive Officer | 723,363 | Nov 20, 2024 | 0 |
| Bornstein Jeffrey S | Director | 110,197 | Jun 7, 2024 | 0 |
| Tomasello Shawn | Director | 70,000 | Jun 7, 2024 | 0 |
| Vera Juan | Director | 2,409,928 | Jun 7, 2024 | 0 |
| Brenner Malcolm | Director | 100,197 | Jun 7, 2024 | 0 |
| Adams Derek N. | Director | 70,000 | Jun 7, 2024 | 0 |
| Piccina Cintia | Chief Commercial Officer | 147,000 | Jul 5, 2023 | 0 |
| Gilead Sciences, Inc. | 10% Owner | 16,635,286 | Jun 28, 2023 | 0 |
| Leen Ann M. | Chief Scientific Officer | 124,006 | Feb 3, 2023 | 0 |
| Van Beek Jeroen B | Chief Commercial Officer | 333,726 | Nov 18, 2022 | 0 |
| Atillasoy Ercem | See Remarks | 131,372 | Oct 26, 2022 | 0 |
| Gadicke Ansbert | Director, 10% Owner | 16,674,766Indirect | Aug 1, 2022 | 0 |
| ElevateBio, LLC | Director, 10% Owner | 16,674,766 | Aug 1, 2022 | 0 |
| Melian Agustin | Chief Medical Officer | 453,529 | Oct 5, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 (view filing) | Apr 2 | 2 days | Sinha VikasSee Remarks | SSale | −885 | $0.77 | −$681.45 | −0.1%1.14M after | |
| Apr 4, 2024 (view filing) | Apr 2 | 2 days | Miller EdwardGeneral Counsel | SSale | −368 | $0.77 | −$283.36 | −0.2%224.6K after | |
| Apr 4, 2024 (view filing) | Apr 2 | 2 days | Brainard DianaChief Executive Officer | SSale | −1.53K | $0.77 | −$1.18K | −0.2%812.5K after | |
| Apr 4, 2024 (view filing) | Apr 2 | 2 days | Hagen Brett RChief Accounting Officer | SSale | −281 | $0.77 | −$216.37 | −0.4%78.6K after | |
| Apr 23, 2024 (view filing) | Apr 19-22 | 4 days | Sinha VikasSee Remarks | SSale | −3.38K | $0.75 | −$2.53K | −0.3%1.14M after | 2 lots |
| Apr 23, 2024 (view filing) | Apr 19-22 | 4 days | Hagen Brett RChief Accounting Officer | SSale | −953 | $0.75 | −$714.75 | −1.2%77.6K after | 2 lots |
| Apr 23, 2024 (view filing) | Apr 19-22 | 4 days | Miller EdwardGeneral Counsel | SSale | −1.38K | $0.75 | −$1.04K | −0.6%223.2K after | 2 lots |
| Apr 23, 2024 (view filing) | Apr 19 | 4 days | Brainard DianaChief Executive Officer | SSale | −9.60K | $0.75 | −$7.20K | −1.2%802.9K after | |
| May 7, 2024 (view filing) | May 3 | 4 days | Miller EdwardGeneral Counsel | SSale | −2.31K | $0.80 | −$1.85K | −1.0%220.9K after | |
| May 7, 2024 (view filing) | May 3 | 4 days | Hagen Brett RChief Accounting Officer | SSale | −1.60K | $0.80 | −$1.28K | −2.1%76.0K after | |
| May 7, 2024 (view filing) | May 3 | 4 days | Sinha VikasSee Remarks | SSale | −4.96K | $0.80 | −$3.97K | −0.4%1.13M after | |
| May 7, 2024 (view filing) | May 3 | 4 days | Brainard DianaChief Executive Officer | SSale | −10.2K | $0.80 | −$8.19K | −1.3%792.7K after | |
| May 21, 2024 (view filing) | May 17 | 4 days | Miller EdwardGeneral Counsel | SSale | −420 | $0.75 | −$315 | −0.2%220.5K after | |
| May 21, 2024 (view filing) | May 17 | 4 days | Sinha VikasSee Remarks | SSale | −3.14K | $0.75 | −$2.36K | −0.3%1.13M after | |
| May 21, 2024 (view filing) | May 17 | 4 days | Brainard DianaChief Executive Officer | SSale | −3.08K | $0.75 | −$2.31K | −0.4%789.6K after | |
| May 21, 2024 (view filing) | May 17 | 4 days | Hagen Brett RChief Accounting Officer | SSale | −541 | $0.75 | −$405.75 | −0.7%75.5K after | |
| May 23, 2024 (view filing) | May 21 | 2 days | Brainard DianaChief Executive Officer | SSale | −5.15K | $0.79 | −$4.07K | −0.7%784.5K after | |
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Brainard DianaChief Executive Officer | SSale | −1.49K | $0.72 | −$1.07K | −0.2%783.0K after | |
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Hagen Brett RChief Accounting Officer | SSale | −304 | $0.72 | −$218.88 | −0.4%75.2K after | |
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Sinha VikasSee Remarks | SSale | −939 | $0.72 | −$676.08 | −0.1%1.17M after | |
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Miller EdwardGeneral Counsel | SSale | −379 | $0.72 | −$272.88 | −0.2%220.1K after | |
| Jul 23, 2024 (view filing) | Jul 19-22 | 4 days | Miller EdwardGeneral Counsel | SSale | −1.39K | $0.7446 | −$1.04K | −0.6%218.7K after | 2 lots |
| Jul 23, 2024 (view filing) | Jul 19-22 | 4 days | Sinha VikasSee Remarks | SSale | −3.40K | $0.7445 | −$2.53K | −0.3%1.16M after | 2 lots |
| Jul 23, 2024 (view filing) | Jul 19 | 4 days | Brainard DianaChief Executive Officer | SSale | −9.73K | $0.75 | −$7.30K | −1.2%773.3K after | |
| Jul 23, 2024 (view filing) | Jul 19-22 | 4 days | Hagen Brett RChief Accounting Officer | SSale | −960 | $0.745 | −$715.19 | −1.3%74.2K after | 2 lots |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Hagen Brett RChief Accounting Officer | SSale | −1.69K | $0.73 | −$1.24K | −2.3%72.5K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Brainard DianaChief Executive Officer | SSale | −10.8K | $0.73 | −$7.92K | −1.4%762.4K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Miller EdwardGeneral Counsel | SSale | −2.32K | $0.73 | −$1.70K | −1.1%216.4K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Sinha VikasSee Remarks | SSale | −5.25K | $0.73 | −$3.83K | −0.5%1.16M after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Brainard DianaChief Executive Officer | SSale | −3.09K | $0.76 | −$2.35K | −0.4%759.3K after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Sinha VikasSee Remarks | SSale | −3.16K | $0.76 | −$2.40K | −0.3%1.15M after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Hagen Brett RChief Accounting Officer | SSale | −544 | $0.76 | −$413.44 | −0.8%72.0K after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Miller EdwardGeneral Counsel | SSale | −422 | $0.76 | −$320.72 | −0.2%216.0K after | |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Brainard DianaChief Executive Officer | SSale | −5.39K | $0.74 | −$3.99K | −0.7%753.9K after | |
| Oct 4, 2024 (view filing) | Oct 3 | 1 day | Hagen Brett RChief Accounting Officer | SSale | −301 | $0.81 | −$243.81 | −0.4%71.7K after | |
| Oct 4, 2024 (view filing) | Oct 3 | 1 day | Brainard DianaChief Executive Officer | SSale | −1.49K | $0.81 | −$1.21K | −0.2%752.4K after | |
| Oct 4, 2024 (view filing) | Oct 3 | 1 day | Miller EdwardGeneral Counsel | SSale | −377 | $0.81 | −$305.37 | −0.2%215.6K after | |
| Oct 4, 2024 (view filing) | Oct 3 | 1 day | Sinha VikasSee Remarks | SSale | −940 | $0.81 | −$761.4 | −0.1%1.15M after | |
| Oct 23, 2024 (view filing) | Oct 21-22 | 2 days | Miller EdwardGeneral Counsel | SSale | −1.40K | $0.7745 | −$1.09K | −0.6%214.2K after | 2 lots |
| Oct 23, 2024 (view filing) | Oct 21 | 2 days | Brainard DianaChief Executive Officer | SSale | −9.75K | $0.78 | −$7.61K | −1.3%742.7K after | |
| Oct 23, 2024 (view filing) | Oct 21-22 | 2 days | Hagen Brett RChief Accounting Officer | SSale | −965 | $0.775 | −$747.84 | −1.3%70.7K after | 2 lots |
| Oct 23, 2024 (view filing) | Oct 21-22 | 2 days | Sinha VikasSee Remarks | SSale | −3.43K | $0.7745 | −$2.66K | −0.3%1.15M after | 2 lots |
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Sinha VikasSee Remarks | SSale | −5.14K | $0.86 | −$4.42K | −0.4%1.14M after | |
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Hagen Brett RChief Accounting Officer | SSale | −1.66K | $0.86 | −$1.42K | −2.3%69.1K after | |
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Miller EdwardGeneral Counsel | SSale | −2.27K | $0.86 | −$1.95K | −1.1%211.9K after | |
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Brainard DianaChief Executive Officer | SSale | −10.6K | $0.86 | −$9.12K | −1.4%732.1K after | |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Brainard DianaChief Executive Officer | SSale | −8.71K | $0.55 | −$4.79K | −1.2%723.4K after | |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Miller EdwardGeneral Counsel | SSale | −432 | $0.55 | −$237.6 | −0.2%211.5K after | |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Sinha VikasSee Remarks | SSale | −3.19K | $0.55 | −$1.75K | −0.3%1.14M after | |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Hagen Brett RChief Accounting Officer | SSale | −554 | $0.55 | −$304.7 | −0.8%68.5K after |